Winnergy Medical PCL
SET:WINMED
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| TH |
W
|
Winnergy Medical PCL
SET:WINMED
|
364m THB |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
113.7B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
68.7B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
70.7B USD |
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
51.4B USD |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
35.1B AUD |
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.4B USD |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
64.3B CNY |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.9B CNY |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
66.4B HKD |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
Market Distribution
| Min | -1 953.8% |
| 30th Percentile | 15.7% |
| Median | 23.9% |
| 70th Percentile | 34.4% |
| Max | 757.3% |
Other Profitability Ratios
Winnergy Medical PCL
Glance View
Winnergy Medical PCL engages in distribution of medical equipment. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2021-05-11. The firm imports high technology medical and diagnostic products from around the world to help improve the lives of people in Thailand. The firm operates through two segments: Revenue from medical products and Revenue from other products. The firm's businesses include trading business and WINMED Laboratory Services. Its trading business includes women healthcare, blood banking, blood safety, cell therapy and other businesses. The firm imports products for cervical cancer detection and surgical gynecology from Hologic Company of the United States. The firm imports products related to blood donation from Haemonetics Company of the United States. The company distributes blood infection test products from Grifols of Spain. The firm imports stem cell and contamination analysis products with specimens from Germany's Miltenyi Biotec.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Winnergy Medical PCL is 41.9%, which is above its 3-year median of 39.2%.
Over the last 3 years, Winnergy Medical PCL’s Gross Margin has increased from 38.4% to 41.9%. During this period, it reached a low of 31.2% on Sep 30, 2024 and a high of 42.9% on Sep 30, 2023.
